Titan Medical (TMDIF) Competitors

$0.28 +0.02 (+7.72%)

As of 05/4/2026

TMDIF vs. VANI, FONR, HSDT, NYXH, and NNOX

Should you be buying Titan Medical stock or one of its competitors? The main competitors of Titan Medical include Vivani Medical (VANI), Fonar (FONR), Solana (HSDT), Nyxoah (NYXH), and Nano-X Imaging (NNOX). These companies are all part of the "medical equipment" industry.

How does Titan Medical compare to Vivani Medical?

Titan Medical (NASDAQ:TMDIF) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

: In the previous week, Vivani Medical had 1 more articles in the media than Titan Medical. MarketBeat recorded 1 mentions for Vivani Medical and 0 mentions for Titan Medical. Titan Medical's average media sentiment score of 0.00 equaled Vivani Medical'saverage media sentiment score.
Company Overall Sentiment
Titan Medical Neutral
Vivani Medical Neutral
: Vivani Medical has a consensus price target of $3.50, indicating a potential upside of 178.88%. Given Vivani Medical's stronger consensus rating and higher possible upside, analysts clearly believe Vivani Medical is more favorable than Titan Medical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Titan Medical
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Vivani Medical
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Titan Medical has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Titan Medical $17.63M 1.82 $6.95M $0.05 5.64
Vivani Medical N/A N/A -$26.61M -$0.43 N/A
: Titan Medical's return on equity of -82.31% beat Vivani Medical's return on equity.
Company Net Margins Return on Equity Return on Assets
Titan Medical N/A -82.31% -51.47%
Vivani Medical N/A -317.03% -82.64%
: Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.35, indicating that its stock price is 135% more volatile than the S&P 500.
: 0.0% of Titan Medical shares are held by institutional investors. Comparatively, 6.8% of Vivani Medical shares are held by institutional investors. 0.0% of Titan Medical shares are held by insiders. Comparatively, 46.4% of Vivani Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Company	Overall Sentiment
Titan Medical	Neutral
Vivani Medical	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	1.82	$6.95M	$0.05	5.64
Vivani Medical	N/A	N/A	-$26.61M	-$0.43	N/A

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Vivani Medical	N/A	-317.03%	-82.64%

Summary

Vivani Medical beats Titan Medical on 7 of the 13 factors compared between the two stocks.

How does Titan Medical compare to Fonar?

Titan Medical (NASDAQ:TMDIF) and Fonar (NASDAQ:FONR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

: 0.0% of Titan Medical shares are held by institutional investors. Comparatively, 50.6% of Fonar shares are held by institutional investors. 0.0% of Titan Medical shares are held by insiders. Comparatively, 1.6% of Fonar shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
: In the previous week, Fonar's average media sentiment score of 1.91 beat Titan Medical's score of 0.00 indicating that Fonar is being referred to more favorably in the news media.
Company Overall Sentiment
Titan Medical Neutral
Fonar Very Positive
: Fonar has higher revenue and earnings than Titan Medical. Titan Medical is trading at a lower price-to-earnings ratio than Fonar, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Titan Medical $17.63M 1.82 $6.95M $0.05 5.64
Fonar $104.35M 1.12 $8.33M $1.13 16.73
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Titan Medical
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Fonar
0 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Fonar has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.
: Fonar has a net margin of 7.13% compared to Titan Medical's net margin of 0.00%. Fonar's return on equity of 4.69% beat Titan Medical's return on equity.
Company Net Margins Return on Equity Return on Assets
Titan Medical N/A -82.31% -51.47%
Fonar 7.13% 4.69% 3.48%

Company	Overall Sentiment
Titan Medical	Neutral
Fonar	Very Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	1.82	$6.95M	$0.05	5.64
Fonar	$104.35M	1.12	$8.33M	$1.13	16.73

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Fonar	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Fonar	7.13%	4.69%	3.48%

Summary

Fonar beats Titan Medical on 11 of the 13 factors compared between the two stocks.

How does Titan Medical compare to Solana?

Titan Medical (NASDAQ:TMDIF) and Solana (NASDAQ:HSDT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

: Titan Medical has higher revenue and earnings than Solana. Solana is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Titan Medical $17.63M 1.82 $6.95M $0.05 5.64
Solana $6.02M 19.66 -$40.89M -$490.68 N/A
: 0.0% of Titan Medical shares are held by institutional investors. Comparatively, 18.6% of Solana shares are held by institutional investors. 0.0% of Titan Medical shares are held by company insiders. Comparatively, 14.4% of Solana shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
: Titan Medical has a net margin of 0.00% compared to Solana's net margin of -679.54%. Titan Medical's return on equity of -82.31% beat Solana's return on equity.
Company Net Margins Return on Equity Return on Assets
Titan Medical N/A -82.31% -51.47%
Solana -679.54% -104.96% -20.67%
: Solana has a consensus price target of $3.50, indicating a potential upside of 62.41%. Given Solana's stronger consensus rating and higher probable upside, analysts clearly believe Solana is more favorable than Titan Medical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Titan Medical
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Solana
1 Sell rating(s)

1 Hold rating(s)

1 Buy rating(s)

1 Strong Buy rating(s)
2.50
: Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Comparatively, Solana has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500.
: In the previous week, Solana had 4 more articles in the media than Titan Medical. MarketBeat recorded 4 mentions for Solana and 0 mentions for Titan Medical. Solana's average media sentiment score of 0.65 beat Titan Medical's score of 0.00 indicating that Solana is being referred to more favorably in the news media.
Company Overall Sentiment
Titan Medical Neutral
Solana Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	1.82	$6.95M	$0.05	5.64
Solana	$6.02M	19.66	-$40.89M	-$490.68	N/A

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Solana	-679.54%	-104.96%	-20.67%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Solana	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Company	Overall Sentiment
Titan Medical	Neutral
Solana	Positive

Summary

Solana beats Titan Medical on 11 of the 17 factors compared between the two stocks.

How does Titan Medical compare to Nyxoah?

Nyxoah (NASDAQ:NYXH) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

: Titan Medical has a net margin of 0.00% compared to Nyxoah's net margin of -884.69%. Titan Medical's return on equity of -82.31% beat Nyxoah's return on equity.
Company Net Margins Return on Equity Return on Assets
Nyxoah -884.69% -139.18% -79.53%
Titan Medical N/A -82.31% -51.47%
: Nyxoah presently has a consensus price target of $9.33, indicating a potential upside of 213.62%. Given Nyxoah's stronger consensus rating and higher possible upside, equities research analysts plainly believe Nyxoah is more favorable than Titan Medical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nyxoah
1 Sell rating(s)
0 Hold rating(s)

3 Buy rating(s)

0 Strong Buy rating(s)
2.50
Titan Medical
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: 0.0% of Titan Medical shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
: Titan Medical has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Nyxoah $11.33M 10.18 -$101.92M -$2.68 N/A
Titan Medical $17.63M 1.82 $6.95M $0.05 5.64
: In the previous week, Nyxoah had 2 more articles in the media than Titan Medical. MarketBeat recorded 2 mentions for Nyxoah and 0 mentions for Titan Medical. Nyxoah's average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.
Company Overall Sentiment
Nyxoah Neutral
Titan Medical Neutral
: Nyxoah has a beta of 1.56, suggesting that its share price is 56% more volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500.

Company	Net Margins	Return on Equity	Return on Assets
Nyxoah	-884.69%	-139.18%	-79.53%
Titan Medical	N/A	-82.31%	-51.47%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$11.33M	10.18	-$101.92M	-$2.68	N/A
Titan Medical	$17.63M	1.82	$6.95M	$0.05	5.64

Company	Overall Sentiment
Nyxoah	Neutral
Titan Medical	Neutral

Summary

Titan Medical beats Nyxoah on 9 of the 15 factors compared between the two stocks.

How does Titan Medical compare to Nano-X Imaging?

Titan Medical (NASDAQ:TMDIF) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

: Titan Medical has a net margin of 0.00% compared to Nano-X Imaging's net margin of -790.87%. Nano-X Imaging's return on equity of -64.65% beat Titan Medical's return on equity.
Company Net Margins Return on Equity Return on Assets
Titan Medical N/A -82.31% -51.47%
Nano-X Imaging -790.87% -64.65% -57.27%
: Nano-X Imaging has a consensus price target of $5.00, suggesting a potential upside of 178.55%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts plainly believe Nano-X Imaging is more favorable than Titan Medical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Titan Medical
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Nano-X Imaging
2 Sell rating(s)

0 Hold rating(s)

1 Buy rating(s)

3 Strong Buy rating(s)
2.83
: 0.0% of Titan Medical shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 0.0% of Titan Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
: Titan Medical has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Titan Medical $17.63M 1.82 $6.95M $0.05 5.64
Nano-X Imaging $13.02M 9.01 -$75.02M -$1.59 N/A
: In the previous week, Nano-X Imaging had 7 more articles in the media than Titan Medical. MarketBeat recorded 7 mentions for Nano-X Imaging and 0 mentions for Titan Medical. Nano-X Imaging's average media sentiment score of 0.23 beat Titan Medical's score of 0.00 indicating that Nano-X Imaging is being referred to more favorably in the news media.
Company Overall Sentiment
Titan Medical Neutral
Nano-X Imaging Neutral
: Titan Medical has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Nano-X Imaging	-790.87%	-64.65%	-57.27%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	1.82	$6.95M	$0.05	5.64
Nano-X Imaging	$13.02M	9.01	-$75.02M	-$1.59	N/A

Company	Overall Sentiment
Titan Medical	Neutral
Nano-X Imaging	Neutral

Summary

Nano-X Imaging beats Titan Medical on 9 of the 17 factors compared between the two stocks.

Get Titan Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMDIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMDIF vs. The Competition

Export

Metric	Titan Medical	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$32.16M	$45.93M	$6.25B	$11.87B
Dividend Yield	N/A	1.08%	2.73%	5.21%
P/E Ratio	-0.23	18.54	29.03	28.47
Price / Sales	1.82	30.61	476.10	60.92
Price / Cash	0.02	18.88	27.62	36.52
Price / Book	0.27	14.27	9.67	6.67
Net Income	$6.95M	-$20.10M	$3.55B	$332.53M
7 Day Performance	-14.55%	-1.31%	1.75%	2.03%
1 Month Performance	2.01%	-1.55%	5.66%	9.23%
1 Year Performance	11.51%	10.87%	34.42%	39.62%

Titan Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMDIF Titan Medical	N/A	$0.28 +7.7%	N/A	N/A	$32.16M	$17.63M	N/A	50	Gap Up
VANI Vivani Medical	2.2458 of 5 stars	$1.36 +1.5%	$3.50 +157.4%	N/A	$117.28M	N/A	N/A	20	News Coverage Upcoming Earnings
FONR Fonar	2.0845 of 5 stars	$18.93 flat	N/A	N/A	$116.86M	$104.35M	16.75	480	Positive News
HSDT Solana	3.4622 of 5 stars	$2.12 +3.9%	$3.50 +65.1%	N/A	$116.37M	$6.02M	N/A	30	Upcoming Earnings
NYXH Nyxoah	2.219 of 5 stars	$3.00 +1.7%	$9.33 +211.1%	N/A	$116.28M	$11.33M	N/A	110	News Coverage Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TMDIF) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Titan Medical (TMDIF) Competitors

TMDIF vs. VANI, FONR, HSDT, NYXH, and NNOX

How does Titan Medical compare to Vivani Medical?

Summary

How does Titan Medical compare to Fonar?

Summary

How does Titan Medical compare to Solana?

Summary

How does Titan Medical compare to Nyxoah?

Summary

How does Titan Medical compare to Nano-X Imaging?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDIF vs. The Competition

Titan Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Titan Medical (TMDIF) Competitors

TMDIF vs. VANI, FONR, HSDT, NYXH, and NNOX

How does Titan Medical compare to Vivani Medical?

Summary

How does Titan Medical compare to Fonar?

Summary

How does Titan Medical compare to Solana?

Summary

How does Titan Medical compare to Nyxoah?

Summary

How does Titan Medical compare to Nano-X Imaging?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDIF vs. The Competition

Titan Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools